Oncology Learning Network Wed, 18 Mar 2026 22:51:36 -0400 https://soundcloud.com/user-771179800 en © 2026 Oncology Learning Network yes 6697093f-8075-5d8a-8f93-51e945b1ef7f HMP Global episodic false Buzzsprout (https://www.buzzsprout.com) HMP Global https://storage.buzzsprout.com/fvjh7quor4t9rwscv9cw849j3qz8?.jpg Oncology Learning Network https://soundcloud.com/user-771179800 Treatment of Recurrent Refractory Pediatric Low-Grade Glioma (pLGG) Treatment of Recurrent Refractory Pediatric Low-Grade Glioma (pLGG) Guest host Cassie Kline, MD, MAS, presents a three-year update from the phase 2 FIREFLY-1 trial evaluating tovorafenib, a weekly oral type II RAF inhibitor, in recurrent or refractory pediatric low-grade glioma. She emphasizes the importance of incorporating clinically meaningful endpoints into future trials, as they may better reflect real-world patient benefit than radiographic criteria alone. 


Dr Kline is a pediatric neuro-oncologist at the Children's Hospital of Philadelphia and is the director of clinical research for the pediatric neuro-oncology group. 

]]> Guest host Cassie Kline, MD, MAS, presents a three-year update from the phase 2 FIREFLY-1 trial evaluating tovorafenib, a weekly oral type II RAF inhibitor, in recurrent or refractory pediatric low-grade glioma. She emphasizes the importance of incorporating clinically meaningful endpoints into future trials, as they may better reflect real-world patient benefit than radiographic criteria alone. 


Dr Kline is a pediatric neuro-oncologist at the Children's Hospital of Philadelphia and is the director of clinical research for the pediatric neuro-oncology group. 

]]> HMP Global Buzzsprout-18432115 Tue, 30 Dec 2025 12:00:00 -0500 535 full false Navigating The Complexity of Melanoma Care: Part 6 Navigating The Complexity of Melanoma Care: Part 6 HMP Global Buzzsprout-17204230 Wed, 21 May 2025 13:00:00 -0400 121 full false Navigating The Complexity of Melanoma Care: Part 5 Navigating The Complexity of Melanoma Care: Part 5 HMP Global Buzzsprout-17204226 Wed, 21 May 2025 13:00:00 -0400 95 full false Navigating The Complexity of Melanoma Care: Part 4 Navigating The Complexity of Melanoma Care: Part 4 HMP Global Buzzsprout-17204225 Wed, 21 May 2025 13:00:00 -0400 160 full false Navigating The Complexity of Melanoma Care: Part 3 Navigating The Complexity of Melanoma Care: Part 3 HMP Global Buzzsprout-17204221 Wed, 21 May 2025 13:00:00 -0400 75 full false Navigating The Complexity of Melanoma Care: Part 2 Navigating The Complexity of Melanoma Care: Part 2 HMP Global Buzzsprout-17204215 Wed, 21 May 2025 13:00:00 -0400 136 full false Navigating The Complexity of Melanoma Care: Part 1 Navigating The Complexity of Melanoma Care: Part 1 HMP Global Buzzsprout-17204208 Wed, 21 May 2025 13:00:00 -0400 166 full false Community Education Program Improves Patient Education and Cancer Screening Rates Community Education Program Improves Patient Education and Cancer Screening Rates HMP Global Buzzsprout-17162484 Wed, 14 May 2025 13:00:00 -0400 421 full false Cholangioscopy: What Interventional Oncologists Need to Know Part 2 Cholangioscopy: What Interventional Oncologists Need to Know Part 2 HMP Global tag:soundcloud,2010:tracks/1901466975 Wed, 21 Aug 2024 15:13:51 -0400 2765 false Cholangioscopy: What Interventional Oncologists Need to Know Cholangioscopy: What Interventional Oncologists Need to Know HMP Global tag:soundcloud,2010:tracks/1901457996 Wed, 21 Aug 2024 14:52:21 -0400 2461 false Applications of AR in Interventional Oncology Applications of AR in Interventional Oncology HMP Global tag:soundcloud,2010:tracks/1852741623 Thu, 20 Jun 2024 09:01:16 -0400 705 false How Artificial Intelligence May Change Interventional Oncology How Artificial Intelligence May Change Interventional Oncology HMP Global tag:soundcloud,2010:tracks/1802129202 Mon, 15 Apr 2024 20:00:00 -0400 1590 false Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial HMP Global tag:soundcloud,2010:tracks/1768173192 Thu, 07 Mar 2024 12:53:50 -0500 451 false Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia On this episode of Blood Bytes, a hematology podcast produced by Oncology Learning Network, Steven Treon, MD, PhD, Director of the Bing Center for Waldenström’s macroglobulinemia at the Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School, Boston, sits down with Christian Buske, MD, Medical Director at the Comprehensive Cancer Center and the Institute of Experimental Cancer Research at the University Ulm, Germany, to discuss recent data surrounding the use of rituximab maintenance for patients with Waldenström macroglobulinemia.

]]> On this episode of Blood Bytes, a hematology podcast produced by Oncology Learning Network, Steven Treon, MD, PhD, Director of the Bing Center for Waldenström’s macroglobulinemia at the Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School, Boston, sits down with Christian Buske, MD, Medical Director at the Comprehensive Cancer Center and the Institute of Experimental Cancer Research at the University Ulm, Germany, to discuss recent data surrounding the use of rituximab maintenance for patients with Waldenström macroglobulinemia.

]]> HMP Global Buzzsprout-14460472 Wed, 07 Feb 2024 16:00:00 -0500 1570 full false Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer HMP Global tag:soundcloud,2010:tracks/1448469685 Thu, 16 Feb 2023 11:58:28 -0500 437 false Advances in Gastrointestinal Genetic Testing Advances in Gastrointestinal Genetic Testing HMP Global tag:soundcloud,2010:tracks/1406546854 Mon, 19 Dec 2022 19:00:00 -0500 291 false Enfortumab Vedotin for Metastatic Urothelial Cancer After Progression on Platinum-Based Chemotherapy Enfortumab Vedotin for Metastatic Urothelial Cancer After Progression on Platinum-Based Chemotherapy HMP Global tag:soundcloud,2010:tracks/1383858355 Tue, 15 Nov 2022 15:28:51 -0500 418 false BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma HMP Global tag:soundcloud,2010:tracks/1314220453 Fri, 29 Jul 2022 12:52:47 -0400 453 false Durvalumab Conveys Benefit for All Biliary Tract Cancer Types Durvalumab Conveys Benefit for All Biliary Tract Cancer Types HMP Global tag:soundcloud,2010:tracks/1309935229 Fri, 22 Jul 2022 11:06:22 -0400 329 false Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements HMP Global tag:soundcloud,2010:tracks/1305225934 Thu, 14 Jul 2022 12:19:01 -0400 272 false Maintenance Cabozantinib in Metastatic Urothelial Carcinoma Maintenance Cabozantinib in Metastatic Urothelial Carcinoma HMP Global tag:soundcloud,2010:tracks/1292415523 Wed, 22 Jun 2022 15:42:45 -0400 291 false Sacituzumab Govitecan Plus Pembrolizumab for Platinum-Refractory Metastatic Urothelial Cancer Sacituzumab Govitecan Plus Pembrolizumab for Platinum-Refractory Metastatic Urothelial Cancer HMP Global tag:soundcloud,2010:tracks/1292403463 Wed, 22 Jun 2022 15:22:00 -0400 525 false Part 2: Overcoming PARP Inhibitor and Platinum Resistance in Patients With Ovarian Cancer Part 2: Overcoming PARP Inhibitor and Platinum Resistance in Patients With Ovarian Cancer HMP Global tag:soundcloud,2010:tracks/1291200082 Mon, 20 Jun 2022 19:47:52 -0400 426 false Part 1: Current Emerging Therapies for Platinum-Resistant Ovarian Malignancies With Dr O'Mally Part 1: Current Emerging Therapies for Platinum-Resistant Ovarian Malignancies With Dr O'Mally HMP Global tag:soundcloud,2010:tracks/1275829894 Thu, 26 May 2022 15:30:03 -0400 588 false Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML HMP Global tag:soundcloud,2010:tracks/1249649704 Wed, 13 Apr 2022 15:28:25 -0400 1500 false Ibrutinib Improves Outcomes Over Rituximab Among Patients With Advanced CLL/SLL Ibrutinib Improves Outcomes Over Rituximab Among Patients With Advanced CLL/SLL HMP Global tag:soundcloud,2010:tracks/1245492640 Wed, 06 Apr 2022 14:58:02 -0400 520 false Evolving Roles of KRAS Inhibitors in CRC Evolving Roles of KRAS Inhibitors in CRC HMP Global tag:soundcloud,2010:tracks/1241689501 Wed, 30 Mar 2022 22:14:23 -0400 105 false The Role of Tumor Mutation Burden Featuring Dr Morris The Role of Tumor Mutation Burden Featuring Dr Morris HMP Global tag:soundcloud,2010:tracks/1241685781 Wed, 30 Mar 2022 22:05:54 -0400 50 false Dr Morris Discusses Emerging Targeted Therapies in mCRC Dr Morris Discusses Emerging Targeted Therapies in mCRC HMP Global tag:soundcloud,2010:tracks/1241684167 Wed, 30 Mar 2022 22:00:33 -0400 182 false Dr Lieu Talks ctDNA to Guide CRC Treatment Dr Lieu Talks ctDNA to Guide CRC Treatment HMP Global tag:soundcloud,2010:tracks/1240772305 Tue, 29 Mar 2022 10:29:14 -0400 195 false Dr Casulo Overviews Approved Treatment Options to Manage Newly Diagnosed, Relapsed FL Dr Casulo Overviews Approved Treatment Options to Manage Newly Diagnosed, Relapsed FL HMP Global tag:soundcloud,2010:tracks/1237420339 Wed, 23 Mar 2022 12:18:33 -0400 320 false Dr Batlevi Shares Promising Data of Tazemetostat from SYMPHONY-1 Trial Dr Batlevi Shares Promising Data of Tazemetostat from SYMPHONY-1 Trial HMP Global tag:soundcloud,2010:tracks/1236233665 Mon, 21 Mar 2022 12:36:47 -0400 286 false Dr Loprinzi Reviews Hot Flash Treatment Strategies in BC, Part II Dr Loprinzi Reviews Hot Flash Treatment Strategies in BC, Part II HMP Global tag:soundcloud,2010:tracks/1232913571 Tue, 15 Mar 2022 17:01:46 -0400 19 false Dr Loprinzi Reviews Hot Flash Treatment Strategies for Patients With Breast Cancer Dr Loprinzi Reviews Hot Flash Treatment Strategies for Patients With Breast Cancer HMP Global tag:soundcloud,2010:tracks/1232661163 Tue, 15 Mar 2022 09:57:18 -0400 217 false Dr Jacob Reviews SunRISe-1 Trial Progress in HR-NMIBC Dr Jacob Reviews SunRISe-1 Trial Progress in HR-NMIBC HMP Global tag:soundcloud,2010:tracks/1225228402 Wed, 02 Mar 2022 15:23:00 -0500 161 false Dr Chi, MD, Discusses Phase 3 MAGNITUDE, SPARTAN, and TITAN Study Results Dr Chi, MD, Discusses Phase 3 MAGNITUDE, SPARTAN, and TITAN Study Results HMP Global tag:soundcloud,2010:tracks/1217553256 Thu, 17 Feb 2022 10:52:00 -0500 190 false Dr Melani Shares Impressive Results of the ViPOR Trial for MCL Dr Melani Shares Impressive Results of the ViPOR Trial for MCL HMP Global tag:soundcloud,2010:tracks/1208658409 Wed, 02 Feb 2022 16:08:19 -0500 516 false Dr Slavin Discusses Ways to Improve PRS by Reducing Ancestral Bias in BC Dr Slavin Discusses Ways to Improve PRS by Reducing Ancestral Bias in BC HMP Global tag:soundcloud,2010:tracks/1178540554 Wed, 15 Dec 2021 16:58:51 -0500 211 false Dr Mascarenhas Discusses AVID200 for Patients With Myelofibrosis Dr Mascarenhas Discusses AVID200 for Patients With Myelofibrosis HMP Global tag:soundcloud,2010:tracks/1178394307 Wed, 15 Dec 2021 12:01:59 -0500 369 false Dr Wildgust Reviews CASSIOPEIA Phase 3 Results in First-Line MM Dr Wildgust Reviews CASSIOPEIA Phase 3 Results in First-Line MM HMP Global tag:soundcloud,2010:tracks/1178391214 Wed, 15 Dec 2021 11:54:41 -0500 386 false Dr Wildgust Discusses Racial Disparities in Treatment Patterns,Outcomes in MM Dr Wildgust Discusses Racial Disparities in Treatment Patterns,Outcomes in MM HMP Global tag:soundcloud,2010:tracks/1178371993 Wed, 15 Dec 2021 11:15:07 -0500 271 false Dr Williams Reviews SunRISe-2 Trial Results for Muscle-Invasive Urothelial Carcinoma Dr Williams Reviews SunRISe-2 Trial Results for Muscle-Invasive Urothelial Carcinoma HMP Global tag:soundcloud,2010:tracks/1164669481 Mon, 22 Nov 2021 10:42:50 -0500 252 false Dr Aggarwal Discusses Plasma-Based Next-Generation Sequencing for Patients with Nonsquamous NSCLC Dr Aggarwal Discusses Plasma-Based Next-Generation Sequencing for Patients with Nonsquamous NSCLC HMP Global tag:soundcloud,2010:tracks/1162010404 Wed, 17 Nov 2021 14:23:22 -0500 177 false Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS HMP Global tag:soundcloud,2010:tracks/1158159511 Thu, 11 Nov 2021 11:06:02 -0500 368 false Dr Elhassadi Highlights the Impact of a p53 Alteration in Patients With MCL Dr Elhassadi Highlights the Impact of a p53 Alteration in Patients With MCL HMP Global tag:soundcloud,2010:tracks/1147628392 Mon, 25 Oct 2021 10:17:07 -0400 357 false Dr Morikawa Discusses Assessing Risk of Brain Metastasis in HER2+ Breast Cancer Dr Morikawa Discusses Assessing Risk of Brain Metastasis in HER2+ Breast Cancer HMP Global tag:soundcloud,2010:tracks/1136598742 Tue, 05 Oct 2021 16:17:37 -0400 108 false Talquetamab Well Tolerated in Relapsed/Refractory MM Talquetamab Well Tolerated in Relapsed/Refractory MM HMP Global tag:soundcloud,2010:tracks/1064358565 Tue, 08 Jun 2021 11:16:12 -0400 264 false Improvements in the Treatment of Patients With MCL Over the Past Decade Improvements in the Treatment of Patients With MCL Over the Past Decade HMP Global tag:soundcloud,2010:tracks/1063846357 Mon, 07 Jun 2021 15:26:46 -0400 275 false Dr Fakih Reviews Upfront Molecular Panel Testing in Metastatic GI Cancers Dr Fakih Reviews Upfront Molecular Panel Testing in Metastatic GI Cancers HMP Global tag:soundcloud,2010:tracks/1063799482 Mon, 07 Jun 2021 13:59:55 -0400 258 false Holly Pederson, MD, Discusses Ancestrally Unbiased Polygenic Breast Cancer Risk Assessment Holly Pederson, MD, Discusses Ancestrally Unbiased Polygenic Breast Cancer Risk Assessment HMP Global tag:soundcloud,2010:tracks/1063759672 Mon, 07 Jun 2021 12:38:58 -0400 689 false Ponatinib Dosing Regimen Demonstrates Improved Responses, Survival in Patients With CP-CML Ponatinib Dosing Regimen Demonstrates Improved Responses, Survival in Patients With CP-CML HMP Global tag:soundcloud,2010:tracks/1062204067 Fri, 04 Jun 2021 18:05:29 -0400 319 false Nirav Shah, MD, Discusses Dual-Targeted CAR T Cells for HL, CLL Nirav Shah, MD, Discusses Dual-Targeted CAR T Cells for HL, CLL HMP Global tag:soundcloud,2010:tracks/1044543046 Fri, 07 May 2021 09:33:44 -0400 206 false ASNS Expression Predicts GLS1 Inhibitor Response in Ovarian Cancer ASNS Expression Predicts GLS1 Inhibitor Response in Ovarian Cancer HMP Global tag:soundcloud,2010:tracks/1035505600 Fri, 23 Apr 2021 17:01:02 -0400 491 false Dr Shitara Discusses Trastuzumab Deruxtecan for Treatment in HER2-Positive Gastric Cancer Dr Shitara Discusses Trastuzumab Deruxtecan for Treatment in HER2-Positive Gastric Cancer HMP Global tag:soundcloud,2010:tracks/987436408 Wed, 17 Feb 2021 10:18:20 -0500 274 false Dr Saad Highlights Results Following the ACIS Study Dr Saad Highlights Results Following the ACIS Study HMP Global tag:soundcloud,2010:tracks/987050779 Tue, 16 Feb 2021 17:37:49 -0500 246 false Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer HMP Global tag:soundcloud,2010:tracks/967615138 Sun, 17 Jan 2021 20:20:22 -0500 203 false Dr Burger Discusses Outcomes Following RESONATE-2 and iLLUMINATE Studies Dr Burger Discusses Outcomes Following RESONATE-2 and iLLUMINATE Studies HMP Global tag:soundcloud,2010:tracks/949607656 Thu, 17 Dec 2020 14:38:16 -0500 471 false Hannah Linden, MD, Highlights AMEERA-1 for ER+/HER2- mBC Hannah Linden, MD, Highlights AMEERA-1 for ER+/HER2- mBC HMP Global tag:soundcloud,2010:tracks/948408850 Wed, 16 Dec 2020 01:48:24 -0500 500 false Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML HMP Global tag:soundcloud,2010:tracks/940648219 Thu, 03 Dec 2020 11:49:53 -0500 107 false Andreas Hochhaus, MD, on Asciminib vs Bosutinib for Pretreated CML-CP Andreas Hochhaus, MD, on Asciminib vs Bosutinib for Pretreated CML-CP HMP Global tag:soundcloud,2010:tracks/940272310 Wed, 02 Dec 2020 19:19:28 -0500 512 false Noopur Raje, MD, Talks Anti-BCMA CAR-T Therapy for Relapsed/Refractory MM Noopur Raje, MD, Talks Anti-BCMA CAR-T Therapy for Relapsed/Refractory MM HMP Global tag:soundcloud,2010:tracks/919177864 Wed, 28 Oct 2020 15:26:52 -0400 474 false Dr Leonard Shares Highlights to Expect at the 2020 Leukemia, Lymphoma & Myeloma Congress Dr Leonard Shares Highlights to Expect at the 2020 Leukemia, Lymphoma & Myeloma Congress HMP Global tag:soundcloud,2010:tracks/913951060 Mon, 19 Oct 2020 19:35:34 -0400 465 false Episode 4: Evolving Therapies in Ewing Sarcoma Episode 4: Evolving Therapies in Ewing Sarcoma HMP Global tag:soundcloud,2010:tracks/911247922 Thu, 15 Oct 2020 15:37:30 -0400 821 false Abhishek Maiti, MD, Talks 10-Day Decitabine Plus Venetoclax for Intensive Chemo–Ineligible AML Abhishek Maiti, MD, Talks 10-Day Decitabine Plus Venetoclax for Intensive Chemo–Ineligible AML HMP Global tag:soundcloud,2010:tracks/911172223 Thu, 15 Oct 2020 13:21:15 -0400 512 false Dr Nagourney on CRC Cells Treated with FOLFOX or CAPOX Dr Nagourney on CRC Cells Treated with FOLFOX or CAPOX HMP Global tag:soundcloud,2010:tracks/903391783 Fri, 02 Oct 2020 08:41:07 -0400 478 false Dr Jazieh Highlights the Prevalence of ALK+ NSCLC in the Middle East and North Africa Dr Jazieh Highlights the Prevalence of ALK+ NSCLC in the Middle East and North Africa HMP Global tag:soundcloud,2010:tracks/901215388 Mon, 28 Sep 2020 17:37:06 -0400 272 false Episode 3: Standard of Care Treatment for Ewing Sarcoma Episode 3: Standard of Care Treatment for Ewing Sarcoma HMP Global tag:soundcloud,2010:tracks/898798648 Thu, 24 Sep 2020 09:29:15 -0400 485 false Sarcoma Soundbites with Brian and Bob: Ewing Sarcoma, Part 1 Sarcoma Soundbites with Brian and Bob: Ewing Sarcoma, Part 1 HMP Global tag:soundcloud,2010:tracks/898794448 Thu, 24 Sep 2020 09:18:51 -0400 485 false Dr Percival on New AML Treatments Dr Percival on New AML Treatments HMP Global tag:soundcloud,2010:tracks/897715018 Tue, 22 Sep 2020 12:58:22 -0400 205 false Combo of RAF/MEK Inhibitor and Defactinib Shows Promise in Patients With KRAS+ Ovarian Cancer Combo of RAF/MEK Inhibitor and Defactinib Shows Promise in Patients With KRAS+ Ovarian Cancer HMP Global tag:soundcloud,2010:tracks/897624118 Tue, 22 Sep 2020 11:34:11 -0400 425 false Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC Veena Shankaran, MD, MS, Discusses Financial Hardships in Patients With Metastatic CRC HMP Global tag:soundcloud,2010:tracks/886406368 Wed, 02 Sep 2020 14:47:04 -0400 489 false What to Expect at the Non-Malignant Hematology Workshop at Lymphoma, Leukemia & Myeloma Congress What to Expect at the Non-Malignant Hematology Workshop at Lymphoma, Leukemia & Myeloma Congress HMP Global tag:soundcloud,2010:tracks/881248834 Mon, 24 Aug 2020 13:24:05 -0400 467 false Dr Jabbour on Management of Ph+ and Ph-like ALL Dr Jabbour on Management of Ph+ and Ph-like ALL HMP Global tag:soundcloud,2010:tracks/879675832 Fri, 21 Aug 2020 11:42:59 -0400 528 false Christopher Crane, MD, Discusses Benefits of Long-Course Vs Short-Course RT for Rectal Cancer Christopher Crane, MD, Discusses Benefits of Long-Course Vs Short-Course RT for Rectal Cancer HMP Global tag:soundcloud,2010:tracks/875917990 Fri, 14 Aug 2020 15:38:01 -0400 383 false CAR T-Cell Therapy Promising for Relapsed, Refractory Large B-Cell NHL CAR T-Cell Therapy Promising for Relapsed, Refractory Large B-Cell NHL HMP Global tag:soundcloud,2010:tracks/870981481 Thu, 06 Aug 2020 00:08:50 -0400 1221 false Long-term Follow Up of First-line NALIRIFOX in Pancreatic Cancer Long-term Follow Up of First-line NALIRIFOX in Pancreatic Cancer HMP Global tag:soundcloud,2010:tracks/850856386 Thu, 02 Jul 2020 10:19:18 -0400 282 false Interim Analysis Suggests Correlation Between Ponatinib Dosing and Efficacy in CML Interim Analysis Suggests Correlation Between Ponatinib Dosing and Efficacy in CML HMP Global tag:soundcloud,2010:tracks/838354726 Thu, 11 Jun 2020 13:13:08 -0400 291 false No DFS Benefit With Adjuvant Atezolizumab for High-Risk Urothelial Carcinoma No DFS Benefit With Adjuvant Atezolizumab for High-Risk Urothelial Carcinoma HMP Global tag:soundcloud,2010:tracks/837039442 Tue, 09 Jun 2020 12:34:57 -0400 214 false Faster Corticosteroid Tapering Safe in Relapsed/Refractory MM Faster Corticosteroid Tapering Safe in Relapsed/Refractory MM HMP Global tag:soundcloud,2010:tracks/834697855 Fri, 05 Jun 2020 11:41:42 -0400 283 false BCMA-Directed CAR-T Therapy Shows Promise in Heavily Pretreated MM BCMA-Directed CAR-T Therapy Shows Promise in Heavily Pretreated MM HMP Global tag:soundcloud,2010:tracks/832896160 Tue, 02 Jun 2020 13:06:26 -0400 264 false Triplet Combo Well-Tolerated, Effective for IDH1-Mutated AML Triplet Combo Well-Tolerated, Effective for IDH1-Mutated AML HMP Global tag:soundcloud,2010:tracks/831669610 Sun, 31 May 2020 11:56:12 -0400 380 false Shirish Gadgeel, MD, Discusses Follow-Up Results of Pembrolizumab with Chemotherapy for NSCLC Shirish Gadgeel, MD, Discusses Follow-Up Results of Pembrolizumab with Chemotherapy for NSCLC HMP Global tag:soundcloud,2010:tracks/809954884 Wed, 29 Apr 2020 14:53:32 -0400 481 false COA Annual Conference Goes Virtual for 2020 COA Annual Conference Goes Virtual for 2020 HMP Global tag:soundcloud,2010:tracks/806357887 Fri, 24 Apr 2020 16:01:24 -0400 283 false Sarcoma Sound Bites with Brian and Bob: Exploring the Territory of TGCT (Part 1) Sarcoma Sound Bites with Brian and Bob: Exploring the Territory of TGCT (Part 1) HMP Global tag:soundcloud,2010:tracks/805347898 Thu, 23 Apr 2020 10:58:56 -0400 468 false Treating Lung Cancer in the COVID-19 Climate Treating Lung Cancer in the COVID-19 Climate HMP Global tag:soundcloud,2010:tracks/793792024 Wed, 08 Apr 2020 10:30:49 -0400 359 false Impact of Text Messaging on Therapy Adherence in Patients With Breast Cancer Impact of Text Messaging on Therapy Adherence in Patients With Breast Cancer HMP Global tag:soundcloud,2010:tracks/787729456 Tue, 31 Mar 2020 13:21:55 -0400 358 false Improving Logistics to Encourage Patient Enrollment in Cancer Clinical Trials Improving Logistics to Encourage Patient Enrollment in Cancer Clinical Trials HMP Global tag:soundcloud,2010:tracks/787727314 Tue, 31 Mar 2020 13:19:02 -0400 197 false Fractures and the Use of Bisphosphonates in Patients With Breast Cancer Fractures and the Use of Bisphosphonates in Patients With Breast Cancer HMP Global tag:soundcloud,2010:tracks/786859843 Mon, 30 Mar 2020 11:27:48 -0400 490 false Michiel Van de Sande, MD, Discusses Multidisciplinary Approach to Treating TGCT Michiel Van de Sande, MD, Discusses Multidisciplinary Approach to Treating TGCT HMP Global tag:soundcloud,2010:tracks/786717715 Mon, 30 Mar 2020 09:01:35 -0400 529 false Post-Transplant TKI Salvage Therapy Provides Significant Survival Benefit Following Relapse in CML Post-Transplant TKI Salvage Therapy Provides Significant Survival Benefit Following Relapse in CML HMP Global tag:soundcloud,2010:tracks/781685983 Mon, 23 Mar 2020 13:29:48 -0400 370 false BTK Inhibitors Important in the Treatment Landscape of MCL BTK Inhibitors Important in the Treatment Landscape of MCL HMP Global tag:soundcloud,2010:tracks/781586461 Mon, 23 Mar 2020 10:49:01 -0400 176 false ACCC President Talks Community Oncology and Bridging the Research Gap ACCC President Talks Community Oncology and Bridging the Research Gap HMP Global tag:soundcloud,2010:tracks/778277896 Wed, 18 Mar 2020 09:57:42 -0400 407 false Direct-to-Patient Strategies in Multiple Myeloma Care Direct-to-Patient Strategies in Multiple Myeloma Care HMP Global tag:soundcloud,2010:tracks/775510351 Fri, 13 Mar 2020 10:45:50 -0400 469 false Kevin Kalinsky, MD, MS, Talks About the Importance of Gene-Profiling for Early-Stage Breast Cancer Kevin Kalinsky, MD, MS, Talks About the Importance of Gene-Profiling for Early-Stage Breast Cancer HMP Global tag:soundcloud,2010:tracks/773211331 Mon, 09 Mar 2020 10:51:27 -0400 358 false Non-Chemotherapy Approach Induces High Rate of Undetectable MRD in CLL Non-Chemotherapy Approach Induces High Rate of Undetectable MRD in CLL HMP Global tag:soundcloud,2010:tracks/767435467 Thu, 27 Feb 2020 11:14:12 -0500 166 false KTE-X19 Shows Great Efficacy in Heavily Pretreated MCL KTE-X19 Shows Great Efficacy in Heavily Pretreated MCL HMP Global tag:soundcloud,2010:tracks/766371061 Tue, 25 Feb 2020 10:59:33 -0500 251 false SEQUOIA Trial: No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer SEQUOIA Trial: No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer HMP Global tag:soundcloud,2010:tracks/765835291 Mon, 24 Feb 2020 11:34:27 -0500 428 false Matt Kalaycio, MD, Discusses the Historical Treatment of CML Matt Kalaycio, MD, Discusses the Historical Treatment of CML HMP Global tag:soundcloud,2010:tracks/765818860 Mon, 24 Feb 2020 11:01:31 -0500 297 false Belantamab Mafodotin Demonstrates Promising Safety and Efficacy for MM Belantamab Mafodotin Demonstrates Promising Safety and Efficacy for MM HMP Global tag:soundcloud,2010:tracks/763852465 Thu, 20 Feb 2020 12:23:06 -0500 228 false Front-Line Ibrutinib Plus Venetoclax Effective for CLL Irrespective of Patient Age Front-Line Ibrutinib Plus Venetoclax Effective for CLL Irrespective of Patient Age HMP Global tag:soundcloud,2010:tracks/763749592 Thu, 20 Feb 2020 09:18:54 -0500 221 false Marginal Zone Lymphoma: Biology and Treatment Marginal Zone Lymphoma: Biology and Treatment HMP Global tag:soundcloud,2010:tracks/763400797 Wed, 19 Feb 2020 16:06:14 -0500 845 false Ruxolitinib-BET Inhibitor Combo Promising for Myelofibrosis Ruxolitinib-BET Inhibitor Combo Promising for Myelofibrosis HMP Global tag:soundcloud,2010:tracks/760580662 Fri, 14 Feb 2020 09:26:58 -0500 304 false iFCG Regimen Effective for Young, Fit Patients With IGHV-Mutated CLL iFCG Regimen Effective for Young, Fit Patients With IGHV-Mutated CLL HMP Global tag:soundcloud,2010:tracks/756653737 Fri, 07 Feb 2020 09:14:26 -0500 227 false Scalp Cooling Device Lowers Risk for Chemo-Related Hair Loss, Gives Patients With Cancer Control Scalp Cooling Device Lowers Risk for Chemo-Related Hair Loss, Gives Patients With Cancer Control HMP Global tag:soundcloud,2010:tracks/750985777 Tue, 28 Jan 2020 08:50:44 -0500 597 false Novel ABL1 Kinase Inhibitor Active in Heavily Pretreated CML Novel ABL1 Kinase Inhibitor Active in Heavily Pretreated CML HMP Global tag:soundcloud,2010:tracks/749040016 Fri, 24 Jan 2020 20:18:38 -0500 352 false Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL HMP Global tag:soundcloud,2010:tracks/748880437 Fri, 24 Jan 2020 14:11:24 -0500 278 false Pacritinib Promising for Patients With Myelofibrosis and Severe Thrombocytopenia Pacritinib Promising for Patients With Myelofibrosis and Severe Thrombocytopenia HMP Global tag:soundcloud,2010:tracks/747056032 Tue, 21 Jan 2020 09:20:31 -0500 282 false Mark Pegram, MD, Discusses the HER2CLIMB Trial and the Promising Nature of Tucatinib Therapy Mark Pegram, MD, Discusses the HER2CLIMB Trial and the Promising Nature of Tucatinib Therapy HMP Global tag:soundcloud,2010:tracks/741317512 Fri, 10 Jan 2020 09:27:26 -0500 1018 false Dr Abou-Alfa Discusses POLO Trial, Olaparib to Treat gBRCA-mutated, Metastatic Pancreatic Cancer Dr Abou-Alfa Discusses POLO Trial, Olaparib to Treat gBRCA-mutated, Metastatic Pancreatic Cancer HMP Global tag:soundcloud,2010:tracks/737974606 Fri, 03 Jan 2020 14:58:27 -0500 169 false Effect of Cost on Adherence to Therapy in Patients With Breast Cancer Effect of Cost on Adherence to Therapy in Patients With Breast Cancer HMP Global tag:soundcloud,2010:tracks/735866512 Mon, 30 Dec 2019 11:23:50 -0500 212 false Encouraging Clinical Trial Participation in Patients With Cancer Encouraging Clinical Trial Participation in Patients With Cancer HMP Global tag:soundcloud,2010:tracks/730247413 Wed, 18 Dec 2019 11:20:27 -0500 95 false Updates in the HER2 Breast Cancer Therapy Space - Part I Updates in the HER2 Breast Cancer Therapy Space - Part I HMP Global tag:soundcloud,2010:tracks/730245964 Wed, 18 Dec 2019 11:19:18 -0500 245 false Updates in the HER2 Breast Cancer Therapy Space - Part II Updates in the HER2 Breast Cancer Therapy Space - Part II HMP Global tag:soundcloud,2010:tracks/730245580 Wed, 18 Dec 2019 11:19:00 -0500 107 false Shanu Modi, MD, Discusses the DESTINY-Breast01 Trial Shanu Modi, MD, Discusses the DESTINY-Breast01 Trial HMP Global tag:soundcloud,2010:tracks/730245334 Wed, 18 Dec 2019 11:18:50 -0500 240 false Novel BTK Inhibitor Shows Promising for Mantle Cell Lymphoma Novel BTK Inhibitor Shows Promising for Mantle Cell Lymphoma HMP Global tag:soundcloud,2010:tracks/729628924 Tue, 17 Dec 2019 15:11:52 -0500 303 false DS-8201a Shows Promise in Treatment of HER2-Positive Breast Cancer DS-8201a Shows Promise in Treatment of HER2-Positive Breast Cancer HMP Global tag:soundcloud,2010:tracks/726552409 Wed, 11 Dec 2019 22:16:11 -0500 71 false Treating Early Stage, HER2-Positive Breast Cancer Treating Early Stage, HER2-Positive Breast Cancer HMP Global tag:soundcloud,2010:tracks/726550330 Wed, 11 Dec 2019 22:13:19 -0500 142 false The Promising Role of Tucatinib in HER2-Positive Breast Cancer Therapy The Promising Role of Tucatinib in HER2-Positive Breast Cancer Therapy HMP Global tag:soundcloud,2010:tracks/726521437 Wed, 11 Dec 2019 21:30:07 -0500 101 false Evolution of the treatment landscape for Tenosynovial Giant Cell Tumors Evolution of the treatment landscape for Tenosynovial Giant Cell Tumors HMP Global tag:soundcloud,2010:tracks/716534971 Thu, 21 Nov 2019 15:25:26 -0500 223 false Pexidartinib Demonstrates Great Tumor Response in Tenosynovial Giant Cell Tumors Pexidartinib Demonstrates Great Tumor Response in Tenosynovial Giant Cell Tumors HMP Global tag:soundcloud,2010:tracks/709950010 Fri, 08 Nov 2019 15:52:09 -0500 319 false Niraparib After First-Line Chemotherapy New Standard of Care for Advanced Ovarian Cancer Niraparib After First-Line Chemotherapy New Standard of Care for Advanced Ovarian Cancer HMP Global tag:soundcloud,2010:tracks/704884087 Tue, 29 Oct 2019 16:31:15 -0400 331 false Amer Zeidan, MBBS, MHS, discusses Myelodysplastic Syndrome(MDS)at 2019 ASH MHM Amer Zeidan, MBBS, MHS, discusses Myelodysplastic Syndrome(MDS)at 2019 ASH MHM HMP Global tag:soundcloud,2010:tracks/701192443 Thu, 24 Oct 2019 14:39:55 -0400 1001 false Newer Treatment Options for Patients With Hodgkin Lymphoma Newer Treatment Options for Patients With Hodgkin Lymphoma HMP Global tag:soundcloud,2010:tracks/698226961 Fri, 18 Oct 2019 09:39:37 -0400 355 false Treating Newly Diagnosed Patients With MCL Treating Newly Diagnosed Patients With MCL HMP Global tag:soundcloud,2010:tracks/697711057 Thu, 17 Oct 2019 09:33:22 -0400 512 false FOxTROT Trial Supports Preoperative Chemotherapy in Colon Cancer, with Matthew Seymour, MD FOxTROT Trial Supports Preoperative Chemotherapy in Colon Cancer, with Matthew Seymour, MD HMP Global tag:soundcloud,2010:tracks/689616289 Tue, 01 Oct 2019 15:14:06 -0400 1157 false Isatuximab Triplet Encouraging for Relapsed/Refractory Multiple Myeloma Isatuximab Triplet Encouraging for Relapsed/Refractory Multiple Myeloma HMP Global tag:soundcloud,2010:tracks/680043455 Thu, 12 Sep 2019 10:02:02 -0400 572 false Neratinib Plus Capecitabine Improves PFS in HER2-Positive Breast Cancer Neratinib Plus Capecitabine Improves PFS in HER2-Positive Breast Cancer HMP Global tag:soundcloud,2010:tracks/659181839 Wed, 31 Jul 2019 15:19:04 -0400 315 false Adding Ribociclib to Endocrine Therapy Improves OS in Young Patients With Advanced Breast Cancer Adding Ribociclib to Endocrine Therapy Improves OS in Young Patients With Advanced Breast Cancer HMP Global tag:soundcloud,2010:tracks/638999340 Wed, 19 Jun 2019 09:15:51 -0400 380 false Ixazomib Promising Maintenance Therapy Option for Multiple Myeloma Ixazomib Promising Maintenance Therapy Option for Multiple Myeloma HMP Global tag:soundcloud,2010:tracks/604434138 Thu, 11 Apr 2019 11:26:11 -0400 122 false Novel Immunotherapy Approaches for Multiple Myeloma Novel Immunotherapy Approaches for Multiple Myeloma HMP Global tag:soundcloud,2010:tracks/604430967 Thu, 11 Apr 2019 11:19:46 -0400 441 false Earlier Daratumamab Use Feasible for Relapsed/Refractory Multiple Myeloma Earlier Daratumamab Use Feasible for Relapsed/Refractory Multiple Myeloma HMP Global tag:soundcloud,2010:tracks/604424805 Thu, 11 Apr 2019 11:05:01 -0400 441 false Survey Results Show Oncologists Want to Learn More About the Needs of LGBTQ Patients Survey Results Show Oncologists Want to Learn More About the Needs of LGBTQ Patients HMP Global tag:soundcloud,2010:tracks/600853992 Thu, 04 Apr 2019 10:14:32 -0400 634 false Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors HMP Global tag:soundcloud,2010:tracks/589001655 Tue, 12 Mar 2019 13:37:45 -0400 658 false Patient Characteristics to Consider for Use of Chemotherapy for Soft-Tissue Sarcoma Patient Characteristics to Consider for Use of Chemotherapy for Soft-Tissue Sarcoma HMP Global tag:soundcloud,2010:tracks/585910434 Wed, 06 Mar 2019 12:47:07 -0500 62 false Are Existing Data Reliable Enough to Support Using Chemo for Soft-Tissue Sarcoma? Are Existing Data Reliable Enough to Support Using Chemo for Soft-Tissue Sarcoma? HMP Global tag:soundcloud,2010:tracks/581806932 Tue, 26 Feb 2019 15:27:54 -0500 78 false Enzalutamide–ADT Combo significantly Improves PFS in Metastatic Hormone-Sensitive Prostate Cancer Enzalutamide–ADT Combo significantly Improves PFS in Metastatic Hormone-Sensitive Prostate Cancer HMP Global tag:soundcloud,2010:tracks/581638737 Tue, 26 Feb 2019 09:14:53 -0500 469 false “Spectacular” Trial Results Establish New Standard of Care for Advanced Kidney Cancer “Spectacular” Trial Results Establish New Standard of Care for Advanced Kidney Cancer HMP Global tag:soundcloud,2010:tracks/578981433 Thu, 21 Feb 2019 09:39:33 -0500 144 false Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC HMP Global tag:soundcloud,2010:tracks/578981427 Thu, 21 Feb 2019 09:39:31 -0500 227 false Survival Benefits of PARP Inhibitors in Metastatic CRPC Favor BRCA1/2 Over ATM Mutations Survival Benefits of PARP Inhibitors in Metastatic CRPC Favor BRCA1/2 Over ATM Mutations HMP Global tag:soundcloud,2010:tracks/578981418 Thu, 21 Feb 2019 09:39:29 -0500 258 false Great Debates in Oncology: Preview of Round 1 - Dr Trent Great Debates in Oncology: Preview of Round 1 - Dr Trent HMP Global tag:soundcloud,2010:tracks/578607810 Wed, 20 Feb 2019 15:26:14 -0500 86 false Practice-Changing Potential in CLL Practice-Changing Potential in CLL HMP Global tag:soundcloud,2010:tracks/577949862 Tue, 19 Feb 2019 11:39:21 -0500 177 false Apalutamide Significantly Delays Metastasis in SPARTAN Trial of Nonmetastatic CRPC Apalutamide Significantly Delays Metastasis in SPARTAN Trial of Nonmetastatic CRPC HMP Global tag:soundcloud,2010:tracks/575415360 Thu, 14 Feb 2019 14:21:50 -0500 526 false New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC HMP Global tag:soundcloud,2010:tracks/575411934 Thu, 14 Feb 2019 14:14:25 -0500 549 false Round 3: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma Round 3: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma HMP Global tag:soundcloud,2010:tracks/567120015 Wed, 30 Jan 2019 08:41:14 -0500 777 false Round 2: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma Round 2: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma HMP Global tag:soundcloud,2010:tracks/563401086 Wed, 23 Jan 2019 09:27:45 -0500 1376 false CLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World Registry CLL Novel Therapy Patterns, Dosing, and Sequencing: Results of the informCLL Real-World Registry HMP Global tag:soundcloud,2010:tracks/562949772 Tue, 22 Jan 2019 10:34:30 -0500 167 false Gemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AML Gemtuzumab Ozogamicin a Safe, Tolerable Option for Patients With Relapsed/Refractory AML HMP Global tag:soundcloud,2010:tracks/548274861 Fri, 21 Dec 2018 10:51:57 -0500 527 false Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML Early Results Show Promise With Venetoclax-Idasanutlin Combo for Relapsed/Refractory AML HMP Global tag:soundcloud,2010:tracks/547796412 Thu, 20 Dec 2018 11:56:42 -0500 401 false Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML Extended Decitabine Dosing Schedule Provides No Benefit Over Shorter Regimen in Newly Diagnosed AML HMP Global tag:soundcloud,2010:tracks/547777752 Thu, 20 Dec 2018 11:16:00 -0500 285 false The Use of CAR-T Therapy for B-Cell Lymphomas Outside of Clinical Trials The Use of CAR-T Therapy for B-Cell Lymphomas Outside of Clinical Trials HMP Global tag:soundcloud,2010:tracks/547436661 Wed, 19 Dec 2018 16:27:23 -0500 417 false Round 1: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma Round 1: The Use of Adjuvant And Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma HMP Global tag:soundcloud,2010:tracks/547244931 Wed, 19 Dec 2018 08:54:11 -0500 1207 false Introduction: The Use of Adjuvant/ Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma Introduction: The Use of Adjuvant/ Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma HMP Global tag:soundcloud,2010:tracks/539766756 Tue, 04 Dec 2018 13:31:18 -0500 77 false Quadruplet Therapy Yields Promising Results in Newly Diagnosed MM Quadruplet Therapy Yields Promising Results in Newly Diagnosed MM HMP Global tag:soundcloud,2010:tracks/537904254 Fri, 30 Nov 2018 14:22:57 -0500 246 false Penn Medicine Looks to Improve Outcomes For Solid Tumors With CAR-T Penn Medicine Looks to Improve Outcomes For Solid Tumors With CAR-T HMP Global tag:soundcloud,2010:tracks/529931223 Wed, 14 Nov 2018 14:45:00 -0500 1328 false Navigating the Treatment Landscape for Multiple Myeloma - Callander Navigating the Treatment Landscape for Multiple Myeloma - Callander HMP Global tag:soundcloud,2010:tracks/526708626 Thu, 08 Nov 2018 11:54:15 -0500 1288 false Cost of Cancer Care in the Outpatient vs Community Oncology Setting - Lucio Gordon Cost of Cancer Care in the Outpatient vs Community Oncology Setting - Lucio Gordon HMP Global tag:soundcloud,2010:tracks/526699161 Thu, 08 Nov 2018 11:33:59 -0500 710 false The Future of CML Treatment: An Interview With Gabriela Hobbs, MD - Part 3 The Future of CML Treatment: An Interview With Gabriela Hobbs, MD - Part 3 HMP Global tag:soundcloud,2010:tracks/526636974 Thu, 08 Nov 2018 09:26:43 -0500 139 false Jonathan Friedberg, MD, Discusses Burkitt Lymphoma Jonathan Friedberg, MD, Discusses Burkitt Lymphoma HMP Global tag:soundcloud,2010:tracks/519220557 Wed, 24 Oct 2018 11:38:54 -0400 61 false Jonathan Friedberg, MD, Discusses The Future of Treatment for Aggressive Lymphomas - Part III Jonathan Friedberg, MD, Discusses The Future of Treatment for Aggressive Lymphomas - Part III HMP Global tag:soundcloud,2010:tracks/519220002 Wed, 24 Oct 2018 11:37:38 -0400 116 false John Leonard, MD, Discusses the Evolving Treatment Landscape for Mantle Cell Lymphoma - Part I John Leonard, MD, Discusses the Evolving Treatment Landscape for Mantle Cell Lymphoma - Part I HMP Global tag:soundcloud,2010:tracks/519174444 Wed, 24 Oct 2018 10:00:23 -0400 135 false Salvage Therapies for CML: An Interview With Gabriela Hobbs, MD - Part II Salvage Therapies for CML: An Interview With Gabriela Hobbs, MD - Part II HMP Global tag:soundcloud,2010:tracks/518763312 Tue, 23 Oct 2018 13:49:03 -0400 246 false Jonathan Friedberg, MD - Treatment for Aggressive Lymphoma and Clinical Implications - Part II Jonathan Friedberg, MD - Treatment for Aggressive Lymphoma and Clinical Implications - Part II HMP Global tag:soundcloud,2010:tracks/518704977 Tue, 23 Oct 2018 11:39:20 -0400 111 false John Leonard, MD - Future Outlook of Mantle Cell Lymphoma Treatment - Part III John Leonard, MD - Future Outlook of Mantle Cell Lymphoma Treatment - Part III HMP Global tag:soundcloud,2010:tracks/518696793 Tue, 23 Oct 2018 11:19:04 -0400 96 false John Leonard, MD - Mantle Cell Lymphoma And Indolent Mantle Cell Lymphoma - Part II John Leonard, MD - Mantle Cell Lymphoma And Indolent Mantle Cell Lymphoma - Part II HMP Global tag:soundcloud,2010:tracks/518696595 Tue, 23 Oct 2018 11:18:32 -0400 176 false John Leonard, MD - FL And Hematology Drugs In The Pipeline - Part IV John Leonard, MD - FL And Hematology Drugs In The Pipeline - Part IV HMP Global tag:soundcloud,2010:tracks/518694354 Tue, 23 Oct 2018 11:13:05 -0400 153 false John Leonard, MD - Future Landscape Of FL Therapy, And Managing Survivors Of FL - Part III John Leonard, MD - Future Landscape Of FL Therapy, And Managing Survivors Of FL - Part III HMP Global tag:soundcloud,2010:tracks/518694069 Tue, 23 Oct 2018 11:12:09 -0400 199 false John Leonard, MD - The Evolving Treatment Landscape for Follicular Lymphoma - Part I John Leonard, MD - The Evolving Treatment Landscape for Follicular Lymphoma - Part I HMP Global tag:soundcloud,2010:tracks/518690466 Tue, 23 Oct 2018 11:03:28 -0400 136 false Dr. Gail Roboz - Clinical Trials and the Future of Treatment in AML – Part III Dr. Gail Roboz - Clinical Trials and the Future of Treatment in AML – Part III HMP Global tag:soundcloud,2010:tracks/518678946 Tue, 23 Oct 2018 10:38:03 -0400 214 false Dr. Gail Roboz - Using Drugs Newly Approved by the FDA to Treat AML - Part II Dr. Gail Roboz - Using Drugs Newly Approved by the FDA to Treat AML - Part II HMP Global tag:soundcloud,2010:tracks/518678100 Tue, 23 Oct 2018 10:35:45 -0400 230 false Dr. Jonathan Friedberg - Barriers to Care in Aggressive Lymphoma - Part 1 Dr. Jonathan Friedberg - Barriers to Care in Aggressive Lymphoma - Part 1 HMP Global tag:soundcloud,2010:tracks/518640984 Tue, 23 Oct 2018 09:00:21 -0400 230 false OLN Interview With Dr. Gail Roboz - Part I OLN Interview With Dr. Gail Roboz - Part I HMP Global tag:soundcloud,2010:tracks/512262540 Wed, 10 Oct 2018 09:15:55 -0400 184 false OLN Interview With Dr. Gabriela Hobbs - Part 1 OLN Interview With Dr. Gabriela Hobbs - Part 1 HMP Global tag:soundcloud,2010:tracks/508344216 Tue, 02 Oct 2018 09:27:59 -0400 209 false Seattle Children's Hospital Leukemia Program Offers Multidisciplinary Care to Underserved Population Seattle Children's Hospital Leukemia Program Offers Multidisciplinary Care to Underserved Population HMP Global tag:soundcloud,2010:tracks/495113895 Tue, 04 Sep 2018 11:47:59 -0400 716 false Showalter - Decline of a "Gold-Standard" Treatment in Cervical Cancer Showalter - Decline of a "Gold-Standard" Treatment in Cervical Cancer HMP Global tag:soundcloud,2010:tracks/495109851 Tue, 04 Sep 2018 11:36:57 -0400 504 false